Literature DB >> 24659621

Translation and validation of the Chinese Cardiff Wound Impact Schedule.

Yao Huang1, Minjie Wu, PengChao Xing, Ting Xie, YeMin Cao, Peifen Qian, Hong Ruan.   

Abstract

The objectives of the study were to translate the Cardiff Wound Impact Schedule (CWIS), a disease-specific quality-of-life measure, into Chinese, and to evaluate its psychometric properties. The CWIS went through the full linguistic translation process and was evaluated in patients with current diabetic foot ulcers (DFU). Patients were categorized using the Wagner grade. Mean CWIS scores were compared between categories to evaluate the scale's ability to differentiate ulcer severity (Wagner grade). There were a total of 131 consecutive patients included in the study. Except item A22 (I am confident that the wound I have will heal), the results of item-domain correlation (r ranged from .391 to .827) and small-group analysis (critical ratio, P < .05) were satisfactory. Furthermore, the Chinese CWIS also demonstrated good criterion validity when correlated with the Short Form-36 (r = .79, P < .01). After deleting item 22, exploratory factor analysis of the items confirmed the existence of 3 hypothesized domains, physical symptoms and daily living (12 items), social life (7 items), and well-being (6 items), and totally explained 57.194% of the variance. The internal consistency of all scales of the Chinese CWIS was consistently high (Cronbach's α ranged from .789 to .929). Split-half reliability was 0.748. Sensitivity was demonstrated between patients with different etiologies of diabetic foot ulcer and those with different ulcer severity (Wagner grade). From the authors' view, the lately validated Chinese CWIS has good psychometric performance and may be appropriately used to assess the health-related quality of life of Chinese patients with DFUs.

Entities:  

Keywords:  CWIS; Wagner grade; diabetic foot ulcers; health-related quality of life

Mesh:

Year:  2014        PMID: 24659621     DOI: 10.1177/1534734614521233

Source DB:  PubMed          Journal:  Int J Low Extrem Wounds        ISSN: 1534-7346            Impact factor:   2.057


  5 in total

1.  Translation, cross-cultural adaptation and validation of the "Cardiff wound impact schedule," a wound-specific quality of life instrument, to the native Spanish of Mexican patients.

Authors:  Adriana Lozano-Platonoff; Jose Contreras-Ruiz; Judith Dominguez-Cherit; Andrea Cardenas-Sanchez; Valeria Alvarez-Rivero; Joel A Martínez-Regalado
Journal:  Int Wound J       Date:  2019-11-11       Impact factor: 3.315

2.  Systematic review on the measurement properties of diabetes-specific patient-reported outcome measures (PROMs) for measuring physical functioning in people with type 2 diabetes.

Authors:  Ellen B M Elsman; Lidwine B Mokkink; Marlous Langendoen-Gort; Femke Rutters; Joline Beulens; Petra J M Elders; Caroline B Terwee
Journal:  BMJ Open Diabetes Res Care       Date:  2022-06

3.  Validation of the Dutch translation of the Cardiff wound impact schedule for evaluation of the health-related quality of life of patients with chronic wounds.

Authors:  Louk P van Doorn; Jasper P Sijberden; Jeroen J W M Brouwers; Lisa Dominique Goossens; Jaap F Hamming
Journal:  Int Wound J       Date:  2020-04-30       Impact factor: 3.315

Review 4.  Content Validity of Patient-Reported Outcome Measures Developed for Assessing Health-Related Quality of Life in People with Type 2 Diabetes Mellitus: a Systematic Review.

Authors:  Caroline B Terwee; Petra J M Elders; Marlous Langendoen-Gort; Ellen B M Elsman; Cecilia A C Prinsen; Amber A van der Heijden; Maartje de Wit; Joline W J Beulens; Lidwine B Mokkink; Femke Rutters
Journal:  Curr Diab Rep       Date:  2022-07-11       Impact factor: 5.430

Review 5.  Patient-reported outcome measures for assessing health-related quality of life in people with type 2 diabetes: A systematic review.

Authors:  Marlous Langendoen-Gort; Lenka Groeneveld; Cecilia A C Prinsen; Joline W Beulens; Petra J M Elders; Ilana Halperin; Geetha Mukerji; Caroline B Terwee; Femke Rutters
Journal:  Rev Endocr Metab Disord       Date:  2022-07-02       Impact factor: 9.306

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.